Skip Header

12 results for author:"Roesch A." in Literature citations

Page 1 of 1

to top of page·  

Results Customize

› Repeat search in UniProtKB (3)

Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.

Fukunaga-Kalabis M., Martinez G., Nguyen T.K., Kim D., Santiago-Walker A., Roesch A., Herlyn M.

Oncogene 29:6115-6124(2010) · Mapped (16)

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Roesch A., Fukunaga-Kalabis M., Schmidt E.C., Zabierowski S.E., Brafford P.A., Vultur A., Basu D., Gimotty P., Vogt T., Herlyn M.

Cell 141:583-594(2010) · Mapped (11)

RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.

Roesch A., Mueller A.M., Stempfl T., Moehle C., Landthaler M., Vogt T.

Int. J. Cancer 122:1047-1057(2008) · Mapped (11)

Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi.

Roesch A., Wittschier S., Becker B., Landthaler M., Vogt T.

Mod. Pathol. 19:1378-1385(2006) · Mapped (1)

Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells.

Roesch A., Becker B., Schneider-Brachert W., Hagen I., Landthaler M., Vogt T.

J. Invest. Dermatol. 126:1850-1859(2006) · UniProtKB (2)

Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro.

Hafner C., Meyer S., Langmann T., Schmitz G., Bataille F., Hagen I., Becker B., Roesch A., Rogler G., Landthaler M. et al.

World J. Gastroenterol. 11:4024-4031(2005) · Mapped (2)

Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.

Roesch A., Becker B., Meyer S., Wild P., Hafner C., Landthaler M., Vogt T.

Mod. Pathol. 18:1249-1257(2005) · UniProtKB (2)

Cloning and characterization of the human FCRL2 gene.

Chikaev N.A., Bykova E.A., Najakshin A.M., Mechetina L.V., Volkova O.Y., Peklo M.M., Shevelev A.Y., Vlasik T.N., Roesch A., Vogt T. et al.

Genomics 85:264-272(2005) · UniProtKB (1) · Mapped (1)

Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma.

Roesch A., Becker B., Meyer S., Hafner C., Wild P.J., Landthaler M., Vogt T.

Mod. Pathol. 18:565-572(2005) · Mapped (18)

Loss of EphB6 expression in metastatic melanoma.

Hafner C., Bataille F., Meyer S., Becker B., Roesch A., Landthaler M., Vogt T.

Int. J. Oncol. 23:1553-1559(2003) · Mapped (1)

Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomas.

Roesch A., Vogt T., Stolz W., Dugas M., Landthaler M., Becker B.

Melanoma Res. 13:503-509(2003) · Mapped (1)

Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis.

Wandersee N.J., Roesch A.N., Hamblen N.R., de Moes J., van der Valk M.A., Bronson R.T., Gimm J.A., Mohandas N., Demant P., Barker J.E.

Blood 97:543-550(2001) · Mapped (3)

to top of page·

Page 1 of 1